RS51969B - 4- (3-Benzoylaminophenyl) -6,7-dimethoxy-2-methylaminoquinazoline derivatives - Google Patents

4- (3-Benzoylaminophenyl) -6,7-dimethoxy-2-methylaminoquinazoline derivatives

Info

Publication number
RS51969B
RS51969B RS20110421A RSP20110421A RS51969B RS 51969 B RS51969 B RS 51969B RS 20110421 A RS20110421 A RS 20110421A RS P20110421 A RSP20110421 A RS P20110421A RS 51969 B RS51969 B RS 51969B
Authority
RS
Serbia
Prior art keywords
methylaminoquinazoline
benzoylaminophenyl
dimethoxy
derivative
optionally substituted
Prior art date
Application number
RS20110421A
Other languages
English (en)
Serbian (sr)
Inventor
Kazutomi Kusano
Kazuki Miyazaki
Yasutaka Takase
Osamu Asano
Manabu Shirato
Hisashi Wakita
Naoto Ishii
Takao Saeki
Original Assignee
Eisai R. & D. Management Co. Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R. & D. Management Co. Ltd. filed Critical Eisai R. & D. Management Co. Ltd.
Publication of RS51969B publication Critical patent/RS51969B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/78Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/84Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
RS20110421A 2006-02-21 2007-02-20 4- (3-Benzoylaminophenyl) -6,7-dimethoxy-2-methylaminoquinazoline derivatives RS51969B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006043273 2006-02-21

Publications (1)

Publication Number Publication Date
RS51969B true RS51969B (en) 2012-02-29

Family

ID=42137992

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20110421A RS51969B (en) 2006-02-21 2007-02-20 4- (3-Benzoylaminophenyl) -6,7-dimethoxy-2-methylaminoquinazoline derivatives

Country Status (18)

Country Link
JP (1) JP4778550B2 (xx)
KR (1) KR101278852B1 (xx)
AT (1) ATE517875T1 (xx)
BR (1) BRPI0708098B8 (xx)
CY (1) CY1112554T1 (xx)
DK (1) DK1992622T3 (xx)
ES (1) ES2368089T3 (xx)
HK (1) HK1122025A1 (xx)
HR (1) HRP20110604T1 (xx)
IL (1) IL193322A (xx)
JO (1) JO2726B1 (xx)
MY (1) MY146275A (xx)
NZ (1) NZ569936A (xx)
PT (1) PT1992622E (xx)
RS (1) RS51969B (xx)
RU (1) RU2431632C2 (xx)
SI (1) SI1992622T1 (xx)
TW (1) TWI404709B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008099887A1 (ja) 2007-02-16 2008-08-21 Eisai R & D Management Co., Ltd. メチル n-[3-(6,7-ジメトキシ-2-メチルアミノキナゾリン-4-イル)フェニル]テレフタラミックアシッドの結晶、非晶質体または塩
CN101687819B (zh) 2007-08-17 2013-03-20 卫材R&D管理有限公司 外用剂
CN102336717B (zh) 2007-08-17 2013-09-18 卫材R&D管理有限公司 喹唑啉衍生物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR015966A1 (es) * 1997-10-17 2001-05-30 Smithkline Beecham Corp Uso de un compuesto inhibidor de pde4 para la preparacion de un medicamento util para el tratamiento de prurito
JPH11209350A (ja) 1998-01-26 1999-08-03 Eisai Co Ltd 含窒素複素環誘導体およびその医薬

Also Published As

Publication number Publication date
IL193322A (en) 2014-04-30
DK1992622T3 (da) 2011-09-05
ATE517875T1 (de) 2011-08-15
HK1122025A1 (xx) 2009-05-08
BRPI0708098B1 (pt) 2019-08-06
KR20080094811A (ko) 2008-10-24
CY1112554T1 (el) 2016-02-10
TW200812980A (en) 2008-03-16
JP4778550B2 (ja) 2011-09-21
RU2008137654A (ru) 2010-03-27
TWI404709B (zh) 2013-08-11
HRP20110604T1 (hr) 2011-09-30
IL193322A0 (en) 2009-05-04
JPWO2007097317A1 (ja) 2009-07-16
JO2726B1 (en) 2013-09-15
SI1992622T1 (sl) 2011-11-30
KR101278852B1 (ko) 2013-07-01
RU2431632C2 (ru) 2011-10-20
MY146275A (en) 2012-07-31
BRPI0708098B8 (pt) 2021-05-25
BRPI0708098A2 (pt) 2011-05-17
PT1992622E (pt) 2011-09-19
NZ569936A (en) 2010-07-30
ES2368089T3 (es) 2011-11-14

Similar Documents

Publication Publication Date Title
MY148703A (en) Polycyclic cinnamide derivatives
MY150507A (en) Polycyclic compound
HK1208868A1 (en) Novel ,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents 2-
MY158982A (en) Heterocyclic compound
WO2009028629A1 (ja) 複素環化合物およびその用途
WO2007125547A3 (en) Novel process for statins and its pharmaceutically acceptable salts thereof
WO2005074603A3 (en) Aminobenzoxazoles as therapeutic agents
WO2009051670A3 (en) Oxylipin compounds for the treatment of ophthalmic conditions
MX342064B (es) Novedoso compuesto de imidazo-oxazina o sal del mismo.
WO2008019395A3 (en) Compounds for improving learning and memory
RS52255B (en) NALMEFEN HYDROCHLORIDE DIHYDRATE
WO2008057775A3 (en) Heterocyclic amide compounds useful as kinase inhibitors
WO2008140066A3 (en) Pyridone derivatives as p38a mapk inhibitors
WO2006039250A3 (en) Chemokine-binding heterocyclic compound salts, and methods of use thereof
GB201305247D0 (en) Amide Compounds
WO2009097515A3 (en) [a]-fused indole compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
WO2006078984A3 (en) Uses of methylphenidate derivatives
CY1112554T1 (el) Παραγωγο 4-(3-βενζοϋλαμινοφαινυλ)-6,7-διμεθοξυ-2-μεθυλαμινοκιναζολινης
WO2010019203A8 (en) Antifungal agents
UA101954C2 (ru) Замещенные ароматические гетероциклические соединения как фунгициды
MY158199A (en) Substituted pyridine compound
MX344516B (es) Bifenoles halogenados como agentes antibacterianos.
TW200634000A (en) 2-(pyrazol-1-yl)pyridine derivatives
MX2010013184A (es) Compuesto heterocíclico.
WO2009111028A8 (en) Aurora kinase inhibitors